The high-stakes nature of nitrosamine impurities in APIs

The presence of nitrosamines in drug products on the market can trigger recalls, causing severe financial and reputational damage. Moreover, during the approval process of a new drug, insufficient data on nitrosamines can lead to costly delays. Download Solvias’ white paper for insights into navigating nitrosamine risks and ensuring compliance with regulations.